Home
Journal Issues
Current Issue
All Issues
In Progress
Contact Us
Create Account
Login
Title
Abstract
Full Text
Keywords
Author
First Name
Last Name
Search
eISSN
:
3080-0382
Biomed adv
. 2026;3(2): 44-46. doi:
10.34172/bma.68
Opinion
Mitochondrial-derived vesicles: Rethinking a quality control pathway as a therapeutic opportunity
Fatima Elmusa
1
, Mohammadreza Dastouri
2
*
Cited by CrossRef:
Submit Your Paper
Editorial Board
Editorial Policies
Aims and Scope
For Authors
Archive
Acceptance Rate:
35%
Submission to First Decision:
20 Days
Received to Acceptance:
60 Days
Acceptance to Publication:
40 Days
*
Average article statistics from the last 12 months of data.
In
collaboration with